The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans

Journal of Psychopharmacology
Joanna K HuxsterMichael J Morgan

Abstract

All previous studies of the sub-acute effects of ecstasy have failed to adequately control for group differences in psychopathology and past and concurrent substance use. The present study was designed to avoid these limitations. At an initial pre-drug baseline, a sample of 38 regular ecstasy users provided full substance histories and completed measures of personality and self-reported psychopathology. We then collected daily subjective measures of mood, cognitive impairment, restless sleep, sexual desire, craving for ecstasy and concomitant use of other substances for the next 9 days. The 20 participants who subsequently opted to take ecstasy during the 9-day assessment period reported modest sub-acute effects of ecstasy on negative mood and subjective cognitive impairment compared to those who did not after controlling for baseline group differences in psychopathology and frequency of ecstasy use. There were no significant sub-acute effects of ecstasy on interest in sexual activity or craving for ecstasy. After further controlling for co-use of alcohol with ecstasy, and the sub-acute effects of ecstasy on sleep, the sub-acute effect on mood remained marginally statistically significant but the subacute effect on cognitive im...Continue Reading

References

Jul 4, 1992·BMJ : British Medical Journal·J A Henry
May 23, 1991·Nature·H J Eysenck
Nov 1, 1995·Progress in Neuro-psychopharmacology & Biological Psychiatry·R S Cohen
Aug 27, 1998·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·F X VollenweiderT Huber
Aug 27, 1998·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·M J Morgan
Oct 27, 1998·Drug and Alcohol Dependence·F SchifanoR Bricolo
Feb 13, 1999·International Clinical Psychopharmacology·G GerraR Delsignore
Mar 18, 1999·Drug and Alcohol Dependence·K L Jansen
Jul 13, 1999·Drug and Alcohol Dependence·L ToppN Solowij
Feb 23, 2000·Neuroreport·A GammaF X Vollenweider
May 24, 2000·Drug and Alcohol Dependence·A C ParrottJ J Turner
Jun 29, 2000·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·M E Liechti, F X Vollenweider
Sep 16, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·M E LiechtiF X Vollenweider
Jun 22, 2001·The American Journal of Drug and Alcohol Abuse·I ElmanD R Gastfriend
Sep 18, 2002·Drug and Alcohol Dependence·Roselind LiebHans Wittchen
Nov 12, 2002·Brain Research·Suzanne ColbronStephany M Biello
Jan 28, 2003·Journal of Affective Disorders·Gordon Parker, Kay Roy
Jun 1, 1961·Archives of General Psychiatry·A T BECKJ ERBAUGH
Oct 9, 2003·Human Psychopharmacology·Suzanne L VerheydenH Valerie Curran
Feb 12, 2004·Journal of Psychopharmacology·Suzanne L VerheydenH Valerie Curran
Oct 19, 2004·Drug and Alcohol Dependence·Raul GonzalezIgor Grant

❮ Previous
Next ❯

Citations

Nov 1, 2011·Psychopharmacology·Rowan P OgeilJillian H Broadbear
May 13, 2008·Drug and Alcohol Dependence·Susan SchenkEvangeline Daniela
Mar 4, 2008·Sleep Medicine Reviews·Thomas SchierenbeckMagdolna Hornyak
Feb 28, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Murray R ThompsonIain S McGregor
Jun 3, 2011·Suicide & Life-threatening Behavior·Jueun KimPing Wu
Mar 31, 2015·Progress in Neuro-psychopharmacology & Biological Psychiatry·Alicia L DanforthCharles S Grob
Jul 24, 2014·Journal of Psychoactive Drugs·Alan K Davis, Harold Rosenberg
May 17, 2014·Journal of Psychoactive Drugs·Jon C Cole
Dec 29, 2012·PloS One·Stanley C FlavelGabrielle Todd
Apr 3, 2003·The American Journal of Emergency Medicine·Shaun L GreeneMary Kerins
Oct 26, 2012·Journal of Psychopharmacology·Rebecca M ScottDan I Lubman
Sep 10, 2010·Journal of Psychopharmacology·Tibor M BruntWim van den Brink
Mar 3, 2006·Journal of Psychopharmacology·Andy C Parrott, Charles A Marsden
Oct 12, 2018·Journal of Clinical Psychopharmacology·Susan Schenk, David Newcombe
Oct 26, 2007·Human Psychopharmacology·Catharine MontgomeryPhilip Murphy
May 10, 2017·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Ben Sessa

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.